amodiaquine has been researched along with Dermatitis Medicamentosa in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Excerpt | Relevance | Reference |
---|---|---|
" Dosage data indicated that fatalities had taken higher doses and continued prophylaxis after onset of symptoms." | 1.28 | Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. ( Phillips-Howard, PA; West, LJ, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SCHLOEDER, FX | 1 |
Phillips-Howard, PA | 1 |
West, LJ | 1 |
2 other studies available for amodiaquine and Dermatitis Medicamentosa
Article | Year |
---|---|
Unusual toxic reaction to amodiaquine (camoquin). Report of a case.
Topics: Amodiaquine; Antimalarials; Drug Eruptions; Humans; Medical Records; Postoperative Complications | 1961 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, | 1990 |